Genrix Bio
68844323.080.52% ( +0.12 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Genrix Bio(688443) the Revenue is 67.25 M (+233.6%);the EBIT is -147.83 M (-20.04%);the EPS is -0.41 (-24.24%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.07B233.63%
----
----
EBIT
-0.15B20.04%
----
----
EPS
-0.4124.24%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf